Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Ting Liu

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
Cancer Medicine|June 19, 2019
Individualized concurrent chemotherapy by pretreatment plasma Epstein-Barr viral DNA in II-III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohortXue-Song Sun, Wen-Hui Chen, Sai-Lan Liu, et al.
Oral Oncology|April 17, 2022
Cost-Effectiveness analysis of combining plasma Epstein-Barr virus DNA testing and different surveillance imaging modalities for nasopharyngeal carcinoma patients in first remissionZhen-Chong Yang, Zhi-Qiang Nie, Qiu-Yan Chen, et al.
Oral Oncology|June 11, 2019
Establishment and validation of a nomogram for predicting survival in patients with de novo metastatic nasopharyngeal carcinomaXue-Song Sun, Yu-Jing Liang, Sai-Lan Liu, et al.
BMC Cancer|December 31, 2018
Symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score-matched analysisYu-Jing Liang, Lin-Quan Tang, Xue-Song Sun, et al.
BMC Cancer|October 9, 2016
With or without reirradiation in advanced local recurrent nasopharyngeal carcinoma: a case-control studyLi-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2026
Long-Term Outcomes of Reduced-Dose Radiotherapy in Patients with Epstein-Barr Virus DNA-Selected Stage III Nasopharyngeal Carcinoma: A 5-Year Follow-Up Secondary Analysis of a Phase II TrialYu-Xi Xiao, Jin-Hao Yang, Xue-Song Sun, et al.
BMJ Oncology|August 5, 2025
Real-world experience on efficacy and safety of different adjuvant chemotherapy regimens in locoregionally advanced nasopharyngeal carcinomaJie Chen, Hui Cheng, Yi-Fu Li, et al.
Cancer Research and Treatment|March 28, 2019
Patterns of Failure and Survival Trends in 3,808 Patients with Stage II Nasopharyngeal Carcinoma Diagnosed from 1990 to 2012: A Large-Scale Retrospective Cohort StudyXue-Song Sun, Di-Han Liu, Sai-Lan Liu, et al.
European Journal of Radiology|September 20, 2025
Potential values of uEXPLORER total-body PET/CT in nasopharyngeal carcinoma: dynamic imaging and kinetic parametersYing-Ying Hu, Zhen-Chong Yang, Li-Ping Liang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 22, 2023
Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinomaYu-Chen, Mei-Juan Luo, Rong-Ping Liu, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
Cancer Medicine|June 19, 2019
Individualized concurrent chemotherapy by pretreatment plasma Epstein-Barr viral DNA in II-III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohortXue-Song Sun, Wen-Hui Chen, Sai-Lan Liu, et al.
Oral Oncology|April 17, 2022
Cost-Effectiveness analysis of combining plasma Epstein-Barr virus DNA testing and different surveillance imaging modalities for nasopharyngeal carcinoma patients in first remissionZhen-Chong Yang, Zhi-Qiang Nie, Qiu-Yan Chen, et al.
Oral Oncology|June 11, 2019
Establishment and validation of a nomogram for predicting survival in patients with de novo metastatic nasopharyngeal carcinomaXue-Song Sun, Yu-Jing Liang, Sai-Lan Liu, et al.
BMC Cancer|December 31, 2018
Symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score-matched analysisYu-Jing Liang, Lin-Quan Tang, Xue-Song Sun, et al.
BMC Cancer|October 9, 2016
With or without reirradiation in advanced local recurrent nasopharyngeal carcinoma: a case-control studyLi-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2026
Long-Term Outcomes of Reduced-Dose Radiotherapy in Patients with Epstein-Barr Virus DNA-Selected Stage III Nasopharyngeal Carcinoma: A 5-Year Follow-Up Secondary Analysis of a Phase II TrialYu-Xi Xiao, Jin-Hao Yang, Xue-Song Sun, et al.
BMJ Oncology|August 5, 2025
Real-world experience on efficacy and safety of different adjuvant chemotherapy regimens in locoregionally advanced nasopharyngeal carcinomaJie Chen, Hui Cheng, Yi-Fu Li, et al.
Cancer Research and Treatment|March 28, 2019
Patterns of Failure and Survival Trends in 3,808 Patients with Stage II Nasopharyngeal Carcinoma Diagnosed from 1990 to 2012: A Large-Scale Retrospective Cohort StudyXue-Song Sun, Di-Han Liu, Sai-Lan Liu, et al.
European Journal of Radiology|September 20, 2025
Potential values of uEXPLORER total-body PET/CT in nasopharyngeal carcinoma: dynamic imaging and kinetic parametersYing-Ying Hu, Zhen-Chong Yang, Li-Ping Liang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 22, 2023
Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinomaYu-Chen, Mei-Juan Luo, Rong-Ping Liu, et al.
Pageof 13